Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 380

1.

Evaluation of a new pan-enteric video capsule endoscopy system in patients with suspected or established inflammatory bowel disease - feasibility study.

Eliakim R, Spada C, Lapidus A, Eyal I, Pecere S, Fernández-Urién I, Lahat A, Costamagna G, Schwartz A, Ron Y, Yanai H, Adler S.

Endosc Int Open. 2018 Oct;6(10):E1235-E1246. doi: 10.1055/a-0677-170. Epub 2018 Oct 8.

2.

Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experience.

Kopylov U, Avni-Biron I, Ron Y, Koslowsky B, Waterman M, Daher S, Ungar B, Schwartz D, Zittan E, Openhaim M, Yanai H, Maharshak N, Bar Gil Shitrit A, Naftali T, Eliakim R, Chowers Y, Ben-Horin S, Dotan I.

Dig Liver Dis. 2018 Aug 10. pii: S1590-8658(18)30877-6. doi: 10.1016/j.dld.2018.07.040. [Epub ahead of print]

PMID:
30172649
3.

Pharmacokinetics and immune reconstitution following discontinuation of thiopurine analogues: Implications for drug withdrawal strategies.

Ben-Horin S, Van Assche G, Chowers Y, Fudim E, Ungar B, Picard O, Yavzori M, Kopylov U, Mao R, Chen MH, Peled-Potashnik Y, Gueta I, Eliakim R, Loebstein R, Markovits N.

J Crohns Colitis. 2018 Aug 27. doi: 10.1093/ecco-jcc/jjy122. [Epub ahead of print]

PMID:
30169593
4.

ECCO-ESGAR Guideline for Diagnostic Assessment in Inflammatory Bowel Disease.

Sturm A, Maaser C, Calabrese E, Annese V, Fiorino G, Kucharzik T, Vavricka SR, Verstockt B, van Rheenen P, Tolan D, Taylor SA, Rimola J, Rieder F, Limdi JK, Laghi A, Krustinš E, Kotze PG, Kopylov U, Katsanos K, Halligan S, Gordon H, González Lama Y, Ellul P, Eliakim R, Castiglione F, Burisch J, Borralho Nunes P, Bettenworth D, Baumgart DC, Stoker J; European Crohn’s and Colitis Organisation [ECCO]; European Society of Gastrointestinal and Abdominal Radiology [ESGAR].

J Crohns Colitis. 2018 Aug 23. doi: 10.1093/ecco-jcc/jjy114. [Epub ahead of print] No abstract available.

PMID:
30137278
5.

ECCO-ESGAR Guideline for Diagnostic Assessment in Inflammatory Bowel Disease.

Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, Calabrese E, Baumgart DC, Bettenworth D, Borralho Nunes P, Burisch J, Castiglione F, Eliakim R, Ellul P, González-Lama Y, Gordon H, Halligan S, Katsanos K, Kopylov U, Kotze PG, Krustinš E, Laghi A, Limdi JK, Rieder F, Rimola J, Taylor SA, Tolan D, van Rheenen P, Verstockt B, Stoker J; European Crohn’s and Colitis Organisation [ECCO]; European Society of Gastrointestinal and Abdominal Radiology [ESGAR].

J Crohns Colitis. 2018 Aug 23. doi: 10.1093/ecco-jcc/jjy113. [Epub ahead of print] No abstract available.

PMID:
30137275
6.

Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn's disease: systematic review and meta-analysis.

Tham YS, Yung DE, Fay S, Yamamoto T, Ben-Horin S, Eliakim R, Koulaouzidis A, Kopylov U.

Therap Adv Gastroenterol. 2018 Jul 8;11:1756284818785571. doi: 10.1177/1756284818785571. eCollection 2018.

7.

Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study.

Friedman MY, Leventer-Roberts M, Rosenblum J, Zigman N, Goren I, Mourad V, Lederman N, Cohen N, Matz E, Dushnitzky DZ, Borovsky N, Hoshen MB, Focht G, Avitzour M, Shachar Y, Chowers Y, Eliakim R, Ben-Horin S, Odes S, Schwartz D, Dotan I, Israeli E, Levi Z, Benchimol EI, Balicer RD, Turner D.

Clin Epidemiol. 2018 Jun 7;10:671-681. doi: 10.2147/CLEP.S151339. eCollection 2018.

8.

Association Between Infliximab Drug and Antibody Levels and Therapy Outcome in Pediatric Inflammatory Bowel Diseases.

Ungar B, Glidai Y, Yavzori M, Picard O, Fudim E, Lahad A, Haberman Y, Shouval DS, Weintraub I, Eliakim R, Ben-Horin S, Weiss B.

J Pediatr Gastroenterol Nutr. 2018 Oct;67(4):507-512. doi: 10.1097/MPG.0000000000002051.

PMID:
29901557
9.

Different clinical outcomes in Crohn's disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype?

Mao R, Tang RH, Qiu Y, Chen BL, Guo J, Zhang SH, Li XH, Feng R, He Y, Li ZP, Zeng ZR, Eliakim R, Ben-Horin S, Chen MH.

Therap Adv Gastroenterol. 2018 Jun 5;11:1756284818777938. doi: 10.1177/1756284818777938. eCollection 2018.

10.

Prospective Observational Evaluation of Time-Dependency of Adalimumab Immunogenicity and Drug Concentrations: The Poetic Study.

Ungar B, Engel T, Yablecovitch D, Lahat A, Lang A, Avidan B, Har-Noy O, Carter D, Levhar N, Selinger L, Neuman S, Natour OH, Yavzori M, Fudim E, Picard O, Kopylov U, Chowers Y, Naftali T, Broide E, Shachar E, Eliakim R, Ben-Horin S.

Am J Gastroenterol. 2018 Jun;113(6):890-898. doi: 10.1038/s41395-018-0073-0. Epub 2018 Jun 5.

PMID:
29867175
11.

Systematic Review and Meta-analysis: Vedolizumab and Postoperative Complications in Inflammatory Bowel Disease.

Yung DE, Horesh N, Lightner AL, Ben-Horin S, Eliakim R, Koulaouzidis A, Kopylov U.

Inflamm Bowel Dis. 2018 Oct 12;24(11):2327-2338. doi: 10.1093/ibd/izy156.

PMID:
29788385
12.

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.

Kopylov U, Verstockt B, Biedermann L, Sebastian S, Pugliese D, Sonnenberg E, Steinhagen P, Arebi N, Ron Y, Kucharzik T, Roblin X, Ungar B, Shitrit AB, Ardizzone S, Molander P, Coletta M, Peyrin-Biroulet L, Bossuyt P, Avni-Biron I, Tsoukali E, Allocca M, Katsanos K, Raine T, Sipponen T, Fiorino G, Ben-Horin S, Eliakim R, Armuzzi A, Siegmund B, Baumgart DC, Kamperidis N, Maharshak N, Maaser C, Mantzaris G, Yanai H, Christodoulou DK, Dotan I, Ferrante M.

Inflamm Bowel Dis. 2018 Oct 12;24(11):2442-2451. doi: 10.1093/ibd/izy155.

PMID:
29788318
13.

Diffusion-weighted magnetic resonance enterography for prediction of response to tumor necrosis factor inhibitors in stricturing Crohn's disease.

Amitai MM, Klang E, Levartovsky A, Rozendorn N, Soffer S, Taha GA, Ungar B, Greener T, Ben-Horin S, Eliakim R, Kopylov U.

Abdom Radiol (NY). 2018 Dec;43(12):3207-3212. doi: 10.1007/s00261-018-1626-9.

PMID:
29779158
14.

Clinical Use of Patency Capsule: A Comprehensive Review of the Literature.

Mitselos IV, Katsanos K, Tsianos EV, Eliakim R, Christodoulou D.

Inflamm Bowel Dis. 2018 Oct 12;24(11):2339-2347. doi: 10.1093/ibd/izy152.

PMID:
29718225
15.

Association of clinical and inflammatory markers with small bowel capsule endoscopy findings in Crohn's disease.

Mitselos IV, Katsanos KH, Tatsioni A, Skamnelos A, Eliakim R, Tsianos EV, Christodoulou DK.

Eur J Gastroenterol Hepatol. 2018 Aug;30(8):861-867. doi: 10.1097/MEG.0000000000001146.

PMID:
29697457
16.

A review of magnetic resonance enterography-based indices for quantification of Crohn's disease inflammation.

Rozendorn N, Amitai MM, Eliakim RA, Kopylov U, Klang E.

Therap Adv Gastroenterol. 2018 Apr 13;11:1756284818765956. doi: 10.1177/1756284818765956. eCollection 2018. Review.

17.

The accuracy of intestinal ultrasound compared with small bowel capsule endoscopy in assessment of suspected Crohn's disease in patients with negative ileocolonoscopy.

Carter D, Katz LH, Bardan E, Salomon E, Goldstein S, Ben Horin S, Kopylov U, Eliakim R.

Therap Adv Gastroenterol. 2018 Apr 9;11:1756284818765908. doi: 10.1177/1756284818765908. eCollection 2018.

18.

Safety, efficacy and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-tumour necrosis factor.

Ben-Horin S, Ungar B, Kopylov U, Lahat A, Yavzori M, Fudim E, Picard O, Peled Y, Eliakim R, Del Tedesco E, Paul S, Roblin X.

Aliment Pharmacol Ther. 2018 Apr;47(8):1117-1125. doi: 10.1111/apt.14567. Epub 2018 Feb 15.

PMID:
29446098
19.

The Lewis score or the capsule endoscopy Crohn's disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn's disease?

Yablecovitch D, Lahat A, Neuman S, Levhar N, Avidan B, Ben-Horin S, Eliakim R, Kopylov U.

Therap Adv Gastroenterol. 2018 Jan 14;11:1756283X17747780. doi: 10.1177/1756283X17747780. eCollection 2018.

20.

Prolonged Recurrent Abdominal Pain is Associated With Ongoing Underlying Mucosal Inflammation in Patients who had an Episode of Acute Complicated Diverticulitis.

Lahat A, Necula D, Yavzori M, Picard O, Halperin S, Eliakim R, Ben-Horin S.

J Clin Gastroenterol. 2018 Jan 19. doi: 10.1097/MCG.0000000000000980. [Epub ahead of print]

PMID:
29356787
21.

Long-Term Outcomes After Primary Bowel Resection in Pediatric-Onset Crohn's Disease.

Rinawi F, Zevit N, Eliakim R, Niv Y, Shamir R, Assa A.

Inflamm Bowel Dis. 2017 Dec 19;24(1):149-158. doi: 10.1093/ibd/izx030.

PMID:
29272491
22.

Capsule Endoscopy, Magnetic Resonance Enterography, and Small Bowel Ultrasound for Evaluation of Postoperative Recurrence in Crohn's Disease: Systematic Review and Meta-Analysis.

Yung DE, Har-Noy O, Tham YS, Ben-Horin S, Eliakim R, Koulaouzidis A, Kopylov U.

Inflamm Bowel Dis. 2017 Dec 19;24(1):93-100. doi: 10.1093/ibd/izx027.

PMID:
29272490
23.

Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases.

Ungar B, Kopylov U, Yavzori M, Fudim E, Picard O, Lahat A, Coscas D, Waterman M, Haj-Natour O, Orbach-Zingboim N, Mao R, Chen M, Chowers Y, Eliakim R, Ben-Horin S.

Clin Gastroenterol Hepatol. 2018 May;16(5):697-705.e7. doi: 10.1016/j.cgh.2017.11.050. Epub 2017 Dec 7.

PMID:
29223444
24.

Capsule Endoscopy Validation of the Magnetic Enterography Global Score in Patients with Established Crohn's Disease.

Klang E, Amitai MM, Lahat A, Yablecovitch D, Avidan B, Neuman S, Levhar N, Rozendorn N, Weiss B, Ben-Horin S, Eliakim R, Kopylov U; Israeli IBD research Nucleus [IIRN).

J Crohns Colitis. 2018 Feb 28;12(3):313-320. doi: 10.1093/ecco-jcc/jjx156.

PMID:
29182750
25.

Capsule endoscopy in young patients with iron deficiency anaemia and negative bidirectional gastrointestinal endoscopy.

Yung DE, Rondonotti E, Giannakou A, Avni T, Rosa B, Toth E, Lucendo AJ, Sidhu R, Beaumont H, Ellul P, Negreanu L, Jiménez-Garcia VA, McNamara D, Kopylov U, Elli L, Triantafyllou K, Shibli F, Riccioni ME, Bruno M, Dray X, Plevris JN, Koulaouzidis A; And the Capsule Endoscopy in Young Patients with IDA research group, Argüelles-Arias F, Becq A, Branchi F, Tejero-Bustos MÁ, Cotter J, Eliakim R, Ferretti F, Gralnek IM, Herrerias-Gutierrez JM, Hussey M, Jacobs M, Johansson GW, McAlindon M, Montiero S, Nemeth A, Pennazio M, Rattehalli D, Stemate A, Tortora A, Tziatzios G.

United European Gastroenterol J. 2017 Nov;5(7):974-981. doi: 10.1177/2050640617692501. Epub 2017 Feb 1.

26.

Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy.

Bar-Yoseph H, Levhar N, Selinger L, Manor U, Yavzori M, Picard O, Fudim E, Kopylov U, Eliakim R, Ben-Horin S, Chowers Y, Ungar B.

Aliment Pharmacol Ther. 2018 Jan;47(2):212-218. doi: 10.1111/apt.14410. Epub 2017 Nov 9.

PMID:
29124774
27.

Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT, Dignass A, Carbonnel F; European Crohn’s and Colitis Organisation [ECCO].

J Crohns Colitis. 2017 Dec 4;11(12):1512. doi: 10.1093/ecco-jcc/jjx105. No abstract available.

PMID:
29088340
28.

Vedolizumab in IBD-Lessons From Real-world Experience; A Systematic Review and Pooled Analysis.

Engel T, Ungar B, Yung DE, Ben-Horin S, Eliakim R, Kopylov U.

J Crohns Colitis. 2018 Jan 24;12(2):245-257. doi: 10.1093/ecco-jcc/jjx143. Review.

PMID:
29077833
29.

Gut colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae may increase disease activity in biologic-naive outpatients with ulcerative colitis: an interim analysis.

Skuja V, Derovs A, Pekarska K, Rudzite D, Lavrinovica E, Piekuse L, Kempa I, Straume Z, Eglite J, Lejnieks A, Krumina A, Eliakim R.

Eur J Gastroenterol Hepatol. 2018 Jan;30(1):92-100. doi: 10.1097/MEG.0000000000000989.

PMID:
29076938
30.

Re-phrasing the question: A simple tool for evaluation of adherence to therapy in patients with inflammatory bowel disease.

Engel T, Ungar B, Ben-Haim G, Levhar N, Eliakim R, Ben-Horin S.

United European Gastroenterol J. 2017 Oct;5(6):880-886. doi: 10.1177/2050640616687838. Epub 2017 Jan 11.

31.

Chromoendoscopy, Narrow-Band Imaging or White Light Endoscopy for Neoplasia Detection in Inflammatory Bowel Diseases.

Har-Noy O, Katz L, Avni T, Battat R, Bessissow T, Yung DE, Engel T, Koulaouzidis A, Eliakim R, Ben-Horin S, Kopylov U.

Dig Dis Sci. 2017 Nov;62(11):2982-2990. doi: 10.1007/s10620-017-4772-y. Epub 2017 Sep 30. Review.

PMID:
28965228
32.

The impact of panenteric capsule endoscopy on the management of Crohn's disease.

Eliakim R.

Therap Adv Gastroenterol. 2017 Sep;10(9):737-744. doi: 10.1177/1756283X17720860. Epub 2017 Jul 24. Review.

33.

The Association Between Drug Levels and Endoscopic Recurrence in Postoperative Patients with Crohn's Disease Treated with Tumor Necrosis Factor Inhibitors.

Fay S, Ungar B, Paul S, Levartovsky A, Yavzori M, Fudim E, Picard O, Eliakim R, Ben-Horin S, Roblin X, Kopylov U.

Inflamm Bowel Dis. 2017 Nov;23(11):1924-1929. doi: 10.1097/MIB.0000000000001220.

PMID:
28837524
34.

Retention rate in small-bowel capsule endoscopy.

Kopylov U, Yung DE, Koulaouzidis A, Eliakim R.

Gastrointest Endosc. 2017 Sep;86(3):573. doi: 10.1016/j.gie.2017.04.011. No abstract available.

PMID:
28826552
35.

Monitoring of small bowel Crohn's disease.

Kopylov U, Koulaouzidis A, Klang E, Carter D, Ben-Horin S, Eliakim R.

Expert Rev Gastroenterol Hepatol. 2017 Nov;11(11):1047-1058. doi: 10.1080/17474124.2017.1359541. Epub 2017 Jul 30. Review.

PMID:
28737951
36.

Assessment of patency capsule retention using MR diffusion-weighted imaging.

Klang E, Kopylov U, Ben-Horin S, Lahat A, Yablecovitch D, Rozendorn N, Eliakim R, Amitai MM.

Eur Radiol. 2017 Dec;27(12):4979-4985. doi: 10.1007/s00330-017-4857-1. Epub 2017 Jul 4.

PMID:
28677060
37.

Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.

Kopylov U, Papamichael K, Katsanos K, Waterman M, Bar-Gil Shitrit A, Boysen T, Portela F, Peixoto A, Szilagyi A, Silva M, Maconi G, Har-Noy O, Bossuyt P, Mantzaris G, Barreiro de Acosta M, Chaparro M, Christodoulou DK, Eliakim R, Rahier JF, Magro F, Drobne D, Ferrante M, Sonnenberg E, Siegmund B, Muls V, Thurm T, Yanai H, Dotan I, Raine T, Levin A, Israeli E, Ghalim F, Carbonnel F, Vermeire S, Ben-Horin S, Roblin X.

Inflamm Bowel Dis. 2017 Sep;23(9):1605-1613. doi: 10.1097/MIB.0000000000001160.

PMID:
28590343
38.

Where do I see minimally invasive endoscopy in 2020: clock is ticking.

Eliakim R.

Ann Transl Med. 2017 May;5(9):202. doi: 10.21037/atm.2017.04.17. Review.

39.

Predictors of pouchitis after ileal pouch-anal anastomosis in pediatric-onset ulcerative colitis.

Rinawi F, Assa A, Eliakim R, Mozer Glassberg Y, Nachmias Friedler V, Niv Y, Rosenbach Y, Silbermintz A, Zevit N, Shamir R.

Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1079-1085. doi: 10.1097/MEG.0000000000000914.

PMID:
28542114
40.

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT, Dignass A, Carbonnel F; European Crohn’s and Colitis Organisation [ECCO].

J Crohns Colitis. 2017 Jul 1;11(7):769-784. doi: 10.1093/ecco-jcc/jjx009. No abstract available.

PMID:
28513805
41.

Diagnostic yield of capsule endoscopy versus magnetic resonance enterography and small bowel contrast ultrasound in the evaluation of small bowel Crohn's disease: Systematic review and meta-analysis.

Kopylov U, Yung DE, Engel T, Vijayan S, Har-Noy O, Katz L, Oliva S, Avni T, Battat R, Eliakim R, Ben-Horin S, Koulaouzidis A.

Dig Liver Dis. 2017 Aug;49(8):854-863. doi: 10.1016/j.dld.2017.04.013. Epub 2017 Apr 27. Review.

PMID:
28512034
42.

Diffusion-weighted imaging in quiescent Crohn's disease: correlation with inflammatory biomarkers and video capsule endoscopy.

Klang E, Kopylov U, Eliakim R, Rozendorn N, Yablecovitch D, Lahat A, Ben-Horin S, Amitai MM.

Clin Radiol. 2017 Sep;72(9):798.e7-798.e13. doi: 10.1016/j.crad.2017.04.006. Epub 2017 May 13.

PMID:
28506799
43.

ECCO-ESCP Consensus on Surgery for Crohn's Disease.

Bemelman WA, Warusavitarne J, Sampietro GM, Serclova Z, Zmora O, Luglio G, de Buck van Overstraeten A, Burke JP, Buskens CJ, Colombo F, Dias JA, Eliakim R, Elosua T, Gecim IE, Kolacek S, Kierkus J, Kolho KL, Lefevre JH, Millan M, Panis Y, Pinkney T, Russell RK, Shwaartz C, Vaizey C, Yassin N, D'Hoore A.

J Crohns Colitis. 2018 Jan 5;12(1):1-16. doi: 10.1093/ecco-jcc/jjx061. No abstract available.

PMID:
28498901
44.

Combination of Corticosteroids with 5-Aminosalicylic Acids Compared to Corticosteroids Alone for Hospitalized Patients with Active Ulcerative Colitis.

Har-Noy O, Kim B, Haiat R, Engel T, Ungar B, Eliakim R, Ho Kim W, Hee Cheon J, Ben-Horin S.

Isr Med Assoc J. 2016 Oct;18(10):613-618.

46.

Association of Induction Infliximab Levels With Clinical Response in Perianal Crohn's Disease.

Davidov Y, Ungar B, Bar-Yoseph H, Carter D, Haj-Natour O, Yavzori M, Chowers Y, Eliakim R, Ben-Horin S, Kopylov U.

J Crohns Colitis. 2017 May 1;11(5):549-555. doi: 10.1093/ecco-jcc/jjw182.

PMID:
28453755
47.

Structural bowel damage in quiescent Crohn's disease.

Amitai MM, Zarchin M, Lahat A, Yablecovitch D, Neuman S, Levhar N, Klang E, Avidan B, Ben-Horin S, Eliakim R, Kopylov U; Israeli IBD research Nucleus (IIRN).

Dig Liver Dis. 2017 May;49(5):490-494. doi: 10.1016/j.dld.2017.02.001. Epub 2017 Feb 13.

PMID:
28233685
48.

Risk of Colectomy in Patients With Pediatric-onset Ulcerative Colitis.

Rinawi F, Assa A, Eliakim R, Mozer-Glassberg Y, Nachmias-Friedler V, Niv Y, Rosenbach Y, Silbermintz A, Zevit N, Shamir R.

J Pediatr Gastroenterol Nutr. 2017 Oct;65(4):410-415. doi: 10.1097/MPG.0000000000001545.

PMID:
28207474
49.

Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn's disease.

Lahat A, Kopylov U, Neuman S, Levhar N, Yablecovitch D, Avidan B, Weiss B, Ben-Horin S, Eliakim R; on behalf of the Israeli IBD research Network (IIRN).

BMC Gastroenterol. 2017 Feb 13;17(1):27. doi: 10.1186/s12876-017-0588-7.

50.

Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience.

Kopylov U, Ron Y, Avni-Biron I, Koslowsky B, Waterman M, Daher S, Ungar B, Yanai H, Maharshak N, Ben-Bassat O, Lichtenstein L, Bar-Gil Shitrit A, Israeli E, Schwartz D, Zittan E, Eliakim R, Chowers Y, Ben-Horin S, Dotan I.

Inflamm Bowel Dis. 2017 Mar;23(3):404-408. doi: 10.1097/MIB.0000000000001039.

PMID:
28178003

Supplemental Content

Loading ...
Support Center